Cipla will report Q1 earnings today. Cipla is up around 52 percent year to date and near that 52-week high level. Revenues this time around are expected to increase because of a lower base in the domestic business.
US sales are expected to normalise, so in terms of revenues expect a 4 percent growth. However on the EBITDA front, it is expected to be a decline of 20 percent, margins are expected to decline by 500 basis points and profits also should see a decline of 29 percent.
Growth in revenues is expected because of the domestic business which is expected to grow by 20-30 percent because the base was very low. As far as US sales are concerned it is expected to increase 6 percent on a sequential basis at that USD 125 million marks which is normalised levels for a company.